ACT Capital Management »

Affimed Therapeutics B V shares owned by ACT Capital Management

Quarter-by-quarter ownership of Affimed Therapeutics B V shares owned by ACT Capital Management from 13F filings

Historical chart of ACT Capital Management investment in Affimed Therapeutics B V

Tip: Access up to 7 years of quarterly data

All positions including Affimed Therapeutics B V held by ACT Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Affimed Therapeutics B V by ACT Capital Management

Quarter filed Position value Share count Share price at filing
2022-09-30 $636k 309k 2.06
2022-06-30 $855k 309k 2.77
2022-03-31 $1.3M 309k 4.37
2021-12-31 $1.7M 309k 5.52
2021-09-30 $1.7M 281k 6.18
2021-06-30 $2.4M 288k 8.50

More positions owned by ACT Capital Management

STAAR Surgical Company (STAA)
Exxon Mobil Corporation (XOM)
Devon Energy Corporation (DVN)
Krystal Biotech (KRYS)
Arrowhead Pharmaceuticals (ARWR)
Axsome Therapeutics (AXSM)
Chevron Corporation (CVX)
Adtran Holdings (ADTN)
Envveno Medical (NVNO)
Clearside Biomedical (CLSD)
Laredo Petroleum (VTLE)
Arcturus Therapeutics Hldg I (ARCT)
Eiger Biopharmaceuticals
Verona Pharma Sponsored Ads (VRNA)
Energy Transfer Com Ut Ltd Ptn (ET)

View all positions for ACT Capital Management

Top funds holding Affimed Therapeutics B V

IFP Advisors
Cape Investment Advisory

View all funds holding Affimed Therapeutics B V